Silver Andrew Jacobinsider trades

In SEC Form 4 filings, Silver Andrew Jacob is listed as Chief Financial Officer of CRISPR Therapeutics AG (CRSP). Silver Andrew Jacob reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 21.

Companies and roles

Company	Role	Transactions	Last filed
CRSPCRISPR Therapeutics AG	Chief Financial Officer	1	Oct 21

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-21

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
CRSPCRISPR Therapeutics AG	Oct 19	Oct 21	A · derivative	25,000	$0.00	$0	25,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.